Correction: Zhang et al., RACK1 recruits STAT3 specifically to insulin and insulin-like growth factor 1 receptors for activation, which is important for regulating anchorageindependent growth [Mol Cell Biol 26, 2, (2006) (413-424)]doi 10.1128/MCB.26.2.413-424.2006;RACK1 recruits STAT3 specifically to insulin and insulin-like growth factor 1 receptors for activation, which is important for regulating anchorage-independent growth

Molecular and Cellular Biology

Volumn 26, Issue 2, 2006, Pages 413-424

  Zhang, Weizhou ^a   Zong, Cong S ^b   Hermanto, Ulrich ^b   Lopez Bergami, Pablo ^a   Ronai, Ze'ev ^c   Wang, Lu Hai ^a,d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c BURNHAM INSTITUTE   (United States)

^d Box 1124 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; INSULIN; INSULIN RECEPTOR; MUTANT PROTEIN; PHOSPHOTYROSINE; PROTEIN RACK1; PROTEIN SH2; RECEPTOR; SOMATOMEDIN C RECEPTOR; STAT PROTEIN; STAT3 PROTEIN; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANOIKIS; ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; COMPLEX FORMATION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PURIFICATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

ANIMALIA;

EID: 30644467070     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00656-16     Document Type: Erratum

References (63)

1. Baker, J., J. P. Liu, E. J. Robertson, and A. Efstratiadis. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82.
2. Berns, H., R. Humar, B. Hengerer, F. N. Kiefer, and E. J. Battegay. 2000. RACK1 is up-regulated in angiogenesis and human carcinomas. FASEB J. 14:2549-2558.
3. Besson, A., T. L. Wilson, and V. W. Yong. 2002. The anchoring protein RACK1 links protein kinase Cε to integrin β chains. Requirements for adhesion and motility. J. Biol. Chem. 277:22073-22084.
4. Bishop, S. M., J. B. Ross, and R. A. Kohnaski. 1999. Autophosphorylation dependent destabilization of the insulin receptor kinase domain: trytophan-1175 reports changes in the catalytic cleft. Biochemistry 38:3079-3089.
5. Blenis, J. 1993. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA 90:5889-5892.
6. Bowman, T., R. Garcia, J. Turkson, and R. Jove. 2000. STATs in oncogenesis. Oncogene 19:2474-2488.
7. Brunet, A., A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, and M. E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96:857-868.
8. Buensuceso, C. S., D. Woodside, J. L. Huff, G. E. Plopper, and T. E. O'Toole. 2001. The WD protein Rack1 mediates protein kinase C and integrin-dependent cell migration. J. Cell Sci. 114:1691-1698.
9. Buettner, R., L. B. Mora, and R. Jove. 2002. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin. Cancer Res. 8:945-954.
10. Calo, V., M. Migliavacca, V. Bazan, M. Macaluso, M. Buscemi, N. Gebbia, and A. Russo. 2003. STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell. Physiol. 197:157-168.
11. Cantley, L. C., K. R. Auger, C. Carpenter, B. Duckworth, A. Graziani, R. Kapeller, and S. Soltoff. 1991. Oncogenes and signal transduction. Cell. 64:281-302.
12. Chang, B. Y., R. A. Harte, and C. A. Cartwright. 2002. RACK1: a novel substrate for the Src protein-tyrosine kinase. Oncogene 21:7619-7629. (Erratum, 22:1748.)
13. Cheatham, B., C. J. Vlahos, L. Cheatham, L. Wang, J. Blenis, and C. R. Kahn. 1994. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14:4902-4911.
14. Chen, C. A., and H. Okayama. 1988. Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. BioTechniques 6:632-638.
15. Chen, J., H. B. Sadowski, R. A. Kohanski, and L. H. Wang. 1997. Stat5 is a physiological substrate of the insulin receptor. Proc. Natl. Acad. Sci. USA 94:2295-2300.
16. Chen, S., B. D. Spiegelberg, F. Lin, E. J. Dell, and H. E. Hamm. 2004. Interaction of Gβγ with RACK1 and other WD40 repeat proteins. J. Mol. Cell Cardiol. 37:399-406.
17. Coffer, P. J., A. van Puijenbroek, B. M. Burgering, M. Klop-de Jonge, L. Koenderman, J. L. Bos, and W. Kruijer. 1997. Insulin activates Stat3 independently of p21ras-ERK and PI-3K signal transduction. Oncogene 15:2529-2539.
18. Cox, E. A., D. Bennin, A. T. Doan, T. O'Toole, A. Huttenlocher. 2003. RACK1 regulates integrin-mediated adhesion, protrusion, and chemotactic cell migration via its Src-binding site. Mol. Biol. Cell 14:658-669.
19. Dalle, S., W. Ricketts, T. Imamura, P. Vollenweider, and J. M. Olefsky. 2001. Insulin and insulin-like growth factor I receptors utilize different G protein signaling components. J. Biol. Chem. 276:15688-15695.
20. Daris, R. J. 1993. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:14553-14556.
21. Datta, S. R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M. E. Greenberg. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241.
22. DeChiara, T. M., E. J. Robertson, and A. Efstratiadis. 1991. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849-859.
23. Decker, T., and P. Kovarik. 2000. Serine phosphorylation of STATs. Oncogene 19:2628-2637.
24. Denley, A., J. C. Wallace, L. J. Cosgrove, and B. E. Forbes. 2003. The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review. Horm. Metab. Res. 35:778-785.
25. Ebina, Y., L. Ellis, K. Jarnagin, M. Edery, L. Graf, E. Clauser, J. H. Ou, F. Masiarz, Y. W. Kan, and I. D. Goldfine. 1985. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signaling. Cell 40:747-758.
26. Graham, F. L., and A. J. Van Der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-457.
27. Gray, S. G., I. Stenfeldt Mathiasen, and P. De Meyts. 2003. The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy? Horm. Metab. Res. 35:857-871.
28. Haro, T., K. Shimoda, H. Kakumitsu, K. Kamezaki, A. Numata, F. Ishikawa, Y. Sekine, R. Muromoto, T. Matsuda, and M. Harada. 2004. Tyrosine kinase 2 interacts with and phosphorylates receptor for activated C kinase-1, a WD motif-containing protein. J. Immunol. 173:1151-1157.
29. He, D. Y., A. J. Vagts, R. Yaka, and D. Ron. 2002. Ethanol induces gene expression via nuclear compartmentalization of receptor for activated C kinase 1. Mol. Pharmacol. 62:272-280.
30. Hermanto, U., C. S. Zong, W. Li, and L. H. Wang. 2002. RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix. Mol. Cell. Biol. 22:2345-2365.
31. Horvath, C. M., Z. Wen, and J. E. Darnell. 1995. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 9:984-994.
32. Jong, S.-M. J., and L.-H. Wang. 1987. The transforming protein P68gag-ros of avian sarcoma virus UR2 is a transmembrane protein with the gag portion protruding extracellularly. Oncogene Res. 1:7-21.
33. Kahn, C. R., and M. F. White. 1988. The insulin receptor and the molecular mechanism of insulin action. J. Clin. Investig. 82:151-156.
34. Kayali, A. G., J. Eichhorn, T. Haruta, A. J. Morris, J. G. Nelson, P. Vollenweider, J. M. Olefsky, and N. J. Webster. 1998. Association of the insulin receptor with phospholipase C-γ (PLCγ) in 3T3-L1 adipocytes suggests a role for PLCγ in metabolic signaling by insulin. J. Biol. Chem. 273:13808-13818.
35. Kiely, P. A., M. Leahy, D. O'Gorman, and R. O'Connor. 2005. RACK1-mediated integration of adhesion and insulin-like growth factor I (IGF-I) signaling and cell migration are defective in cells expressing an IGF-I receptor mutated at tyrosines 1250 and 1251. J. Biol. Chem. 280:7624-7633.
36. Kiely, P. A., A. Sant, and R. O'Connor. 2002. RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death. J. Biol. Chem. 277:22581-22589.
37. Kubota, T., N. Yokosawa, S. Yokota, and N. Fujii. 2002. Association of mumps virus V protein with RACK1 results in dissociation of STAT-1 from the alpha interferon receptor complex. J. Virol. 76:12676-12682.
38. Le, M. N., R. A. Kohanski, L. H. Wang, and H. B. Sadowski. 2002. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor. Mol. Endocrinol. 16:2764-2779.
39. LeRoith, D., and C. T. Roberts, Jr. 2003. The insulin-like growth factor system and cancer. Cancer Lett. 95:127-137.
40. Liu, J. P., J. Baker, A. S. Perkins, E. J. Robertson, and A. Efstratiadis. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72.
41. Liu, D., C. S. Zong, and L. H. Wang. 1993. Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signaling functions. J. Virol. 67:6835-6840.
42. López-Bergami P., H. Habelhah, A. Bhoumik, W. Zhang, L. H. Wang, and Z. Ronai. Receptor for activated C kinase 1 (RACK1) mediates activation of Jun N-terminal Kinase (JNK) by protein kinase C. Mol. Cell 19:309-320. (Erratum, 19:578-579.)
43. 1/S progression by suppressing Src kinase activity. Mol. Cell. Biol. 24:6788-6798.
44. McCahill, A., J. Warwicker, G. B. Bolger, M. D. Houslay, and S. J. Yarwood. 2002. The RACK1 scaffold protein: a dynamic cog in cell response mechanisms. Mol. Pharmacol. 62:1261-1273.
45. Mochly-Rosen, D., B. L. Smith, C. H. Chen, M. H. Disatnik, and D. Ron. 1995. Interaction of protein kinase C with RACK1, a receptor for activated C-kinase; a role in beta protein kinase C mediated signal transduction. Biochem. Soc. Trans. 23:596-600.
46. Niu, G., K. L. Wright, M. Huang, L. Song, E. Haura, J. Turkson, S. Zhang, T. Wang, D. Sinibaldi, D. Coppola, R. Heller, L. M. Ellis, J. Karras, J. Bromberg, D. Pardoll, R. Jove, and H. Yu. 2002. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21:2000-2008.
47. O'Connor, R. 2003. Regulation of IGF-1 receptor signaling in tumor cells. Horm. Metab. Res. 35:771-777.
48. Schlessinger, J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103:211-225.
49. Scimeca, J. C., R. Ballotti, T. T. Nguyen, C. Filloux, and E. Van Obberghen. 1991. Tyrosine and threonine phosphorylation of an immunoaffinity-purified 44-kDa MAP kinase. Biochemistry 30:9313-9319.
50. Skolnik, E. Y., A. Batzer, N. Li, C. H. Lee, E. Lowenstein, M. Mohammadi, B. Margolis, and J. Schlessinger. 1993. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 260:1953-1955.
51. Storz, P., H. Doppler, K. Pfizenmaier, and G. Muller. 1999. Insulin selectively activates STAT5b, but not STAT5a, via a JAK2-independent signalling pathway in Kym-1 rhabdomyosarcoma cells. FEBS Lett. 464:159-163.
52. Thornton, C., K. C. Tang, K. Phamluong, K. Luong, A. Vagts, D. Nikanjam, R. Yaka, and D. Ron. 2004. Spatial and temporal regulation of RACK1 function and N-methyl-D-aspartate receptor activity through WD40 motif-mediated dimerization. J. Biol. Chem. 279:31357-31364.
53. Turkson, J., T. Bowman, R. Garcia, E. Caldenhoven, R. P. De Groot, and R. Jove. 1998. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18:2545-2552.
54. Usacheva, A., R. Smith, R. Minshall, G. Baida, S. Seng, E. Croze, and O. Colamonici. 2001. The WD motif-containing protein receptor for activated protein kinase C (RACK1) is required for recruitment and activation of signal transducer and activator of transcription 1 through the type I interferon receptor. J. Biol. Chem. 276:22948-22953.
55. Uttamsingh, S., C. S. Zong, and L. H. Wang. 2003. Matrix-independent activation of phosphatidylinositol 3-kinase, Stat3, and cyclin A-associated Cdk2 is essential for anchorage-independent growth of v-Ros-transformed chicken embryo fibroblasts. J. Biol. Chem. 278:18798-18810.
56. Van Obberghen, E., V. Baron, L. Delahaye, B. Emanuelli, N. Filippa, S. Giorgetti-Peraldi, P. Lebrun, I. Mothe-Satney, P. Peraldi, S. Rocchi, D. Sawka-Verhelle, S. Tartare-Deckert, and J. Giudicelli. 2001. Surfing the insulin signaling web. Eur. J. Clin. Investig. 31:966-977.
57. Van Obberghen, E. 1994. Signalling through the insulin receptor and the insulin-like growth factor-I receptor. Diabetologia. Suppl. 2:S125-S134.
58. Wall, M. A., D. E. Coleman, E. Lee, J. A. Iniguez-Lluhi, B. A. Posner, A. G. Gilman, and S. R. Sprang. 1995. The structure of the G protein heterotrimer Giα1β1χ2. Cell 83:1047-1058.
59. Wang, Q., R. Somwar, P. J. Bilan, Z. Liu, J. Jin, J. R. Woodgett, and A. Klip. 1999. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol. Cell. Biol. 19:4008-4018.
60. Wilden, P. A., and C. R. Kahn. 1994. The level of insulin receptor tyrosine kinase activity modulates the activities of phosphatidylinositol 3-kinase, microtubule-associated protein, and S6 kinases. Mol. Endocrinol. 8:558-567.
61. Xiong, Q., J. L.-K. Chan, C. Zong, and L.-H. Wang. 1996. Two chimeric receptors of epidermal growth factor receptor and c-Ros that differ in their transmembrane domains have opposite effects on cell growth. Mol. Cell. Biol. 16:1509-1518.
62. Zeng, L., P. Sachdev, L. Yan, J. L. Chan, T. Trenkle, M. McClelland, J. Welsh, and L. H. Wang. 2000. Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation. Mol. Cell. Biol. 20:9212-9224.
63. Zong, C. S., J. Chan, D. E. Levy, C. Horvath, H. B. Sadowski, and L. H. Wang. 2000. Mechanism of STAT3 activation by insulin-like growth factor 1 receptor. J. Biol. Chem. 275:15099-15105.